开始
欲了解 Precision NanoSystems 如何加速从创意到临床应用的纳米药物研发过程,请联系我们的技术销售团队。
取得联系
NanoAssemblr GMP System: Is a modular and configurable system, fit-for-purpose and phase appropriate, for the GMP manufacturing of nanomedicines.
Flexible, Efficient & Reproducible
Clinical Development
NanoAssemblr Technology: Ensures that the nanoparticle formation conditions are uniform, controlled and reproducible. Results in faster development times, easier scale up and higher production yields.
连续流动微流控平台专为
Nanoparticles manufactured on the GMP System are functionally similar to those produced with the NanoAssemblr® Benchtop and Blaze.
脂质纳米颗粒
脂质体
Multiple microfluidic devices can perform the same operation in parallel to increase throughput.
乳剂
聚合物纳米颗粒
核酸脂质纳米颗粒 (LNP) 制备。缓冲液中的核酸(左)和溶剂中的脂质纳米颗粒前体(右)注入微流控试剂盒的两个入口,两者以可控的方式混合。通过改变相对流速和总流速,可以制备粒径大小不同的脂质纳米颗粒(最右)。
Poster
September 01, 2022
Application Note
March 15, 2022
Publication - Abstract
July 01, 2020
Journal of Controlled Release
Publication - Abstract
May 08, 2020
Vaccines
Publication - Abstract
April 02, 2020
Journal of Controlled Release